Atrolak (quetiapine): Reviews and patient testimonials
Back to the list of medications
Medication indications
Atrolak XL 150 mg prolonged-release tablets
Atrolak XL is indicated for:
• treatment of Schizophrenia
• treatment of bipolar disorder :
| o For the treatment of moderate to severe manic episodes in bipolar disorder o For the treatment of major depressive episodes in bipolar disorder o For the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment |
• add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see Section 5.1). Prior to initiating treatment, clinicians should consider the safety profile of Atrolak XL (see Section 4.4).
Atrolak XL 200 mg prolonged-release tablets
Atrolak XL tablet is indicated for:
• treatment of Schizophrenia
• treatment of bipolar disorder:
- For the treatment of moderate to severe manic episodes in bipolar disorder
- For the treatment of major depressive episodes in bipolar disorder
- For the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment
• Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see Section 5.1). Prior to initiating treatment, clinicians should consider the safety profile of Atrolak XL tablet (see Section 4.4).
Atrolak XL 300 mg prolonged-release tablets
Atrolak XL tablet is indicated for:
• treatment of Schizophrenia
• treatment of bipolar disorder:
- For the treatment of moderate to severe manic episodes in bipolar disorder
- For the treatment of major depressive episodes in bipolar disorder
- For the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment
• Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see Section 5.1). Prior to initiating treatment, clinicians should consider the safety profile of Atrolak XL tablet (see Section 4.4).
Atrolak XL 400 mg prolonged-release tablets
Atrolak XL tablet is indicated for:
• treatment of Schizophrenia
• treatment of bipolar disorder:
- For the treatment of moderate to severe manic episodes in bipolar disorder
- For the treatment of major depressive episodes in bipolar disorder
- For the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment
• Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see Section 5.1). Prior to initiating treatment, clinicians should consider the safety profile of Atrolak XL tablet (see Section 4.4).
Atrolak XL 50 mg prolonged-release tablets
Atrolak XL 50 mg is indicated for:
• treatment of Schizophrenia
• treatment of bipolar disorder :
- For the treatment of moderate to severe manic episodes in bipolar disorder
- For the treatment of major depressive episodes in bipolar disorder
- For the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment.
• Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see Section 5.1). Prior to initiating treatment, clinicians should consider the safety profile of Atrolak XL 50 mg (see Section 4.4).
Route of administration: Oral
Molecule: quetiapine
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.